Article(id=1208073009877852439, tenantId=1146029695717560320, journalId=1189873630562394117, issueId=1208073005197009056, articleNumber=null, orderNo=null, doi=10.11855/j.issn.0577-7402.2022.05.0511, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=research-article, receivedDate=1621440000000, receivedDateStr=2021-05-20, revisedDate=null, revisedDateStr=null, acceptedDate=1636041600000, acceptedDateStr=2021-11-05, onlineDate=1765956650466, onlineDateStr=2025-12-17, pubDate=1653667200000, pubDateStr=2022-05-28, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1765956650466, onlineIssueDateStr=2025-12-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1765956650466, creator=13701087609, updateTime=1765956650466, updator=13701087609, issue=Issue{id=1208073005197009056, tenantId=1146029695717560320, journalId=1189873630562394117, year='2022', volume='47', issue='5', pageStart='427', pageEnd='532', issueExtLink='null', onlineDate='null', pubDate='null', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=0, createTime=1765956649350, creator=13701087609, updateTime=1765956710955, updator=13701087609, preIssue=null, nextIssue=null, ext={EN=IssueExt(id=1208073263641633510, tenantId=1146029695717560320, journalId=1189873630562394117, issueId=1208073005197009056, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1208073263641633511, tenantId=1146029695717560320, journalId=1189873630562394117, issueId=1208073005197009056, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null}, startPage=511, endPage=517, ext={EN=ArticleExt(id=1208073010171453738, articleId=1208073009877852439, tenantId=1146029695717560320, journalId=1189873630562394117, language=EN, title=Research progress in the treatment of glioblastoma by nose-to-brain delivery, columnId=1190243275882729994, journalTitle=Medical Journal of Chinese People’s Liberation Army, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Glioblastoma (GBM) is a most common primary malignant brain tumor characterized by rapid growth and invasion of surrounding tissues. At present, the standard methods for treatment of GBM include surgical resection, radiotherapy and chemotherapy. Because the existence of blood-brain barrier (BBB) restricts the delivery of anti-cancer drugs into the brain,novel drug deliver approaches are urgently needed to improve the therapeutic effect of GBM. As a non-invasive alternative route for directly targeting the central nervous system (CNS) disease, nose-to-brain delivery could bypass the BBB and reduce the systemic side effects. Recently, several formulations have been developed for further enhancing nose-to-brain transport, mainly with the use of nanostructured drug delivery systems. The application of nose-to-brain delivery combined with different anticancer drugs or methods in clinical treatment of GBM have been reviewed in present paper.

, correspAuthors=Hai-Long Zhao, authorNote=null, correspAuthorsNote=, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, authorCompany=null, fund=null, authors=null, authorsList=Wen-Wen Li, Rui Lai, Qi Liu, Hai-Long Zhao), CN=ArticleExt(id=1208073010800599373, articleId=1208073009877852439, tenantId=1146029695717560320, journalId=1189873630562394117, language=CN, title=经鼻脑给药途径治疗胶质母细胞瘤研究进展, columnId=1190243276029530637, journalTitle=解放军医学杂志, columnName=综述, runingTitle=null, highlight=null, articleAbstract=

胶质母细胞瘤(GBM)是最常见的原发性恶性脑肿瘤，其特征是肿瘤快速生长及侵袭周围组织。目前治疗GBM的标准方法包括手术切除、放射疗法和化学药物疗法，由于血脑屏障(BBB)会限制多种抗癌药物进入脑内，因此迫切需要新的给药途径以提高治疗效果。目前，鼻脑给药途径作为一种非侵入性替代途径，能够绕过BBB治疗中枢神经系统(CNS)疾病，并减少全身性不良反应。新近开发的多种新型制剂主要通过纳米结构的药物递送系统来进一步增强鼻脑转运。本文就鼻脑给药途径联合不同抗癌药物或方式在GBM临床治疗中的应用研究进展进行综述。

, correspAuthors=赵海龙, authorNote=null, correspAuthorsNote=, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=2njSUufdgT68AJv7i+km9Q==, magXml=T2zKMC+qY6JxfNEG6DhsRw==, pdfUrl=null, pdf=BY92eUASbdiOb1kWqLb7Mw==, pdfFileSize=993380, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=g6GGK7ECmd4pG9fo2V8JMw==, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=PalIoa7+JrmJ3FkuK/UYCw==, mapNumber=null, authorCompany=null, fund=null, authors=, authorsList=李吻吻, 赖睿, 刘淇, 赵海龙)}, authors=[Author(id=1208073012620927361, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1208073012725784969, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073012620927361, language=EN, stringName=Wen-Wen Li, firstName=Wen-Wen, middleName=null, lastName=Li, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=¹Department of Pathophysiology, School of Preclinical Medicine, Zunyi Medical University, Zunyi, Guizhou 563000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1208073012864197007, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073012620927361, language=CN, stringName=李吻吻, firstName=吻吻, middleName=null, lastName=李, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=¹, address=¹遵义医科大学基础医学院病理生理学教研室，贵州遵义 563000, bio={"content":"

李吻吻，硕士研究生，主要从事肿瘤细胞微环境和细胞间相互作用的研究

"}, bioImg=null, bioContent=

李吻吻，硕士研究生，主要从事肿瘤细胞微环境和细胞间相互作用的研究

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1208073012125999458, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=1, ext=[AuthorCompanyExt(id=1208073012130193763, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012125999458, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹Department of Pathophysiology, School of Preclinical Medicine, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012138582372, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012125999458, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹遵义医科大学基础医学院病理生理学教研室，贵州遵义 563000)])]), Author(id=1208073012964860311, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1208073013044552093, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073012964860311, language=EN, stringName=Rui Lai, firstName=Rui, middleName=null, lastName=Lai, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=², address=²First Clinical College, Zunyi Medical University, Zunyi, Guizhou 563000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1208073013149409701, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073012964860311, language=CN, stringName=赖睿, firstName=睿, middleName=null, lastName=赖, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=², address=²遵义医科大学第一临床学院，贵州遵义 563000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1208073012281188715, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=2, ext=[AuthorCompanyExt(id=1208073012289577324, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012281188715, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=²First Clinical College, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012302160237, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012281188715, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=²遵义医科大学第一临床学院，贵州遵义 563000)])]), Author(id=1208073013245878699, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1208073013359124920, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073013245878699, language=EN, stringName=Qi Liu, firstName=Qi, middleName=null, lastName=Liu, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=³, address=³School of Stomatology, Zunyi Medical University, Zunyi, Guizhou 563000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1208073013443011005, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073013245878699, language=CN, stringName=刘淇, firstName=淇, middleName=null, lastName=刘, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=³, address=³遵义医科大学口腔医学院，贵州遵义 563000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1208073012432183669, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=3, ext=[AuthorCompanyExt(id=1208073012474126712, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012432183669, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=³School of Stomatology, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012486709623, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012432183669, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=³遵义医科大学口腔医学院，贵州遵义 563000)])]), Author(id=1208073013547868614, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=hailongzhao@zmu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1208073013665309134, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073013547868614, language=EN, stringName=Hai-Long Zhao, firstName=Hai-Long, middleName=null, lastName=Zhao, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=^{1, *}, address=¹Department of Pathophysiology, School of Preclinical Medicine, Zunyi Medical University, Zunyi, Guizhou 563000, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1208073013761778130, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, authorId=1208073013547868614, language=CN, stringName=赵海龙, firstName=海龙, middleName=null, lastName=赵, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=^{1, *}, address=¹遵义医科大学基础医学院病理生理学教研室，贵州遵义 563000, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1208073012125999458, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=1, ext=[AuthorCompanyExt(id=1208073012130193763, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012125999458, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹Department of Pathophysiology, School of Preclinical Medicine, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012138582372, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012125999458, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹遵义医科大学基础医学院病理生理学教研室，贵州遵义 563000)])])], keywords=[Keyword(id=1208073013895995863, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=EN, orderNo=1, keyword=nasal delivery), Keyword(id=1208073013988270559, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=EN, orderNo=2, keyword=glioblastoma), Keyword(id=1208073014080545253, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=EN, orderNo=3, keyword=blood-brain barrier), Keyword(id=1208073014168625641, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=EN, orderNo=4, keyword=nose-to-brain delivery), Keyword(id=1208073014265094639, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=EN, orderNo=5, keyword=stem cells), Keyword(id=1208073014357369332, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=CN, orderNo=1, keyword=鼻腔输送), Keyword(id=1208073014474809850, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=CN, orderNo=2, keyword=胶质母细胞瘤), Keyword(id=1208073014562890238, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=CN, orderNo=3, keyword=血脑屏障), Keyword(id=1208073014667747846, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=CN, orderNo=4, keyword=鼻脑给药), Keyword(id=1208073014785188364, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=CN, orderNo=5, keyword=干细胞)], refs=[Reference(id=1208073017532457558, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2013, volume=15, issue=Suppl 2, pageStart=ii1, pageEnd=ii56, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=Ostrom QT, Gittleman H, Farah P, journalName=Neuro Oncol, refType=null, unstructuredReference=Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010[J]. Neuro Oncol, 2013, 15(Suppl 2): ii1-ii56., articleTitle=CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010, refAbstract=null), Reference(id=1208073017603760730, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2014, volume=23, issue=10, pageStart=1985, pageEnd=1996, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=Thakkar JP, Dolecek TA, Horbinski C, journalName=Cancer Epidemiol Biomarkers Prev, refType=null, unstructuredReference=Thakkar JP, Dolecek TA, Horbinski C, et al. Epidemiologic and molecular prognostic review of glioblastoma[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(10): 1985-1996., articleTitle=Epidemiologic and molecular prognostic review of glioblastoma, refAbstract=null), Reference(id=1208073017691841119, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2015, volume=4, issue=2, pageStart=55, pageEnd=57, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=Morsy AA, Ng WH, journalName=CNS Oncol, refType=null, unstructuredReference=Morsy AA, Ng WH. Re-do craniotomy for recurrent glioblastoma[J]. CNS Oncol, 2015, 4(2): 55-57., articleTitle=Re-do craniotomy for recurrent glioblastoma, refAbstract=null), Reference(id=1208073017788310115, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2005, volume=352, issue=10, pageStart=987, pageEnd=996, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=Stupp R, Mason WP, van den Bent MJ, journalName=N Engl J Med, refType=null, unstructuredReference=Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352(10): 987-996., articleTitle=Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, refAbstract=null), Reference(id=1208073017880584809, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=8, issue=1, pageStart=7222, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=Tiek DM, Rone JD, Graham GT, journalName=Sci Rep, refType=null, unstructuredReference=Tiek DM, Rone JD, Graham GT, et al. Alterations in cell motility, proliferation, and metabolism in novel models of acquired temozolomide resistant glioblastoma[J]. Sci Rep, 2018, 8(1):7222., articleTitle=Alterations in cell motility, proliferation, and metabolism in novel models of acquired temozolomide resistant glioblastoma, refAbstract=null), Reference(id=1208073017977053804, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=8, issue=null, pageStart=462, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=Harder BG, Blomquist MR, Wang J, journalName=Front Oncol, refType=null, unstructuredReference=Harder BG, Blomquist MR, Wang J, et al. Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma[J]. Front Oncol, 2018, 8:462., articleTitle=Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma, refAbstract=null), Reference(id=1208073018073522800, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=18, issue=1, pageStart=34, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=Schaffenrath J, Huang SF, Wyss T, journalName=Fluids Barriers CNS, refType=null, unstructuredReference=Schaffenrath J, Huang SF, Wyss T, et al. Characterization of the blood-brain barrier in genetically diverse laboratory mouse strains[J]. Fluids Barriers CNS, 2021, 18(1): 34., articleTitle=Characterization of the blood-brain barrier in genetically diverse laboratory mouse strains, refAbstract=null), Reference(id=1208073018186769011, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2012, volume=32, issue=11, pageStart=1959, pageEnd=1972, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=Pardridge WM, journalName=J Cereb Blood Flow Metab, refType=null, unstructuredReference=Pardridge WM. Drug transport across the blood-brain barrier[J]. J Cereb Blood Flow Metab, 2012, 32(11): 1959-1972., articleTitle=Drug transport across the blood-brain barrier, refAbstract=null), Reference(id=1208073018274849399, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2016, volume=22, issue=9, pageStart=1177, pageEnd=1193, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=Hersh DS, Wadajkar AS, Roberts N, journalName=Curr Pharm Des, refType=null, unstructuredReference=Hersh DS, Wadajkar AS, Roberts N, et al. Evolving drug delivery strategies to overcome the blood brain barrier[J]. Curr Pharm Des, 2016, 22(9): 1177-1193., articleTitle=Evolving drug delivery strategies to overcome the blood brain barrier, refAbstract=null), Reference(id=1208073018350346872, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=8, issue=6, pageStart=1481, pageEnd=1493, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=Dong X, journalName=Theranostics, refType=null, unstructuredReference=Dong X. Current strategies for brain drug delivery[J]. Theranostics, 2018, 8(6): 1481-1493., articleTitle=Current strategies for brain drug delivery, refAbstract=null), Reference(id=1208073018446815868, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=11, issue=10, pageStart=540, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=Hong SS, Oh KT, Choi HG, journalName=Pharmaceutics, refType=null, unstructuredReference=Hong SS, Oh KT, Choi HG, et al. Liposomal formulations for nose-to-brain delivery: Recent advances and future perspectives[J]. Pharmaceutics, 2019, 11(10): 540., articleTitle=Liposomal formulations for nose-to-brain delivery: Recent advances and future perspectives, refAbstract=null), Reference(id=1208073018522313344, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=195, issue=null, pageStart=44, pageEnd=52, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=Crowe TP, Greenlee MHW, Kanthasamy AG, journalName=Life Sci, refType=null, unstructuredReference=Crowe TP, Greenlee MHW, Kanthasamy AG, et al. Mechanism of intranasal drug delivery directly to the brain[J]. Life Sci, 2018, 195: 44-52., articleTitle=Mechanism of intranasal drug delivery directly to the brain, refAbstract=null), Reference(id=1208073018614588034, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=9, issue=1, pageStart=2621, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=Lochhead JJ, Kellohen KL, Ronaldson PT, journalName=Sci Rep, refType=null, unstructuredReference=Lochhead JJ, Kellohen KL, Ronaldson PT, et al. Distribution of insulin in trigeminal nerve and brain after intranasal administration[J]. Sci Rep, 2019, 9(1): 2621., articleTitle=Distribution of insulin in trigeminal nerve and brain after intranasal administration, refAbstract=null), Reference(id=1208073018702668420, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2013, volume=10, issue=7, pageStart=957, pageEnd=972, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=Pardeshi CV, Belgamwar VS, journalName=Expert Opin Drug Deliv, refType=null, unstructuredReference=Pardeshi CV, Belgamwar VS. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier:an excellent platform for brain targeting[J]. Expert Opin Drug Deliv, 2013, 10(7): 957-972., articleTitle=Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood–brain barrier:an excellent platform for brain targeting, refAbstract=null), Reference(id=1208073018786554502, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=10, issue=3, pageStart=116, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=Ganger S, Schindowski K, journalName=Pharmaceutics, refType=null, unstructuredReference=Ganger S, Schindowski K. Tailoring formulations for intranasal nose-to-brain delivery: A review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa[J]. Pharmaceutics, 2018, 10(3): 116., articleTitle=Tailoring formulations for intranasal nose-to-brain delivery: A review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa, refAbstract=null), Reference(id=1208073018883023497, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2014, volume=5, issue=6, pageStart=709, pageEnd=733, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=Djupesland PG, Messina JC, Mahmoud RA, journalName=Ther Deliv, refType=null, unstructuredReference=Djupesland PG, Messina JC, Mahmoud RA. The nasal approach to delivering treatment for brain diseases: An anatomic, physiologic, and delivery technology overview [J]. Ther Deliv, 2014, 5(6): 709-733., articleTitle=The nasal approach to delivering treatment for brain diseases: An anatomic, physiologic, and delivery technology overview, refAbstract=null), Reference(id=1208073018987881098, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=14, issue=null, pageStart=5895, pageEnd=5909, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=Alexander A, Agrawal M, Uddin A, journalName=Int J Nanomedicine, refType=null, unstructuredReference=Alexander A, Agrawal M, Uddin A, et al. Recent expansions of novel strategies towards the drug targeting into the brain[J]. Int J Nanomedicine, 2019, 14: 5895-5909., articleTitle=Recent expansions of novel strategies towards the drug targeting into the brain, refAbstract=null), Reference(id=1208073019084350093, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=10, issue=7, pageStart=439, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=Trevino JT, Quispe RC, Khan F, journalName=J Clin Trials, refType=null, unstructuredReference=Trevino JT, Quispe RC, Khan F, et al. Non-invasive strategies for nose-to-brain drug delivery[J]. J Clin Trials, 2020, 10(7): 439., articleTitle=Non-invasive strategies for nose-to-brain drug delivery, refAbstract=null), Reference(id=1208073019185013392, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=603, issue=null, pageStart=120714, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=Ferreira NN, de Oliveira Junior E, Granja S, journalName=Int J Pharm, refType=null, unstructuredReference=Ferreira NN, de Oliveira Junior E, Granja S, et al. Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system[J]. Int J Pharm, 2021, 603: 120714., articleTitle=Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system, refAbstract=null), Reference(id=1208073019298259604, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=25, issue=1, pageStart=185, pageEnd=194, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=Sabir F, Ismail R, Csoka I, journalName=Drug Discov Today, refType=null, unstructuredReference=Sabir F, Ismail R, Csoka I. Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: Status quo and outlook[J]. Drug Discov Today, 2020, 25(1):185-194., articleTitle=Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: Status quo and outlook, refAbstract=null), Reference(id=1208073019361174167, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=10, issue=4, pageStart=1044, pageEnd=1056, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=Upadhaya PG, Pulakkat S, Patravale VB, journalName=Drug Deliv Transl Res, refType=null, unstructuredReference=Upadhaya PG, Pulakkat S, Patravale VB. Nose-to-brain delivery: Exploring newer domains for glioblastoma multiforme management[J]. Drug Deliv Transl Res, 2020, 10(4):1044-1056., articleTitle=Nose-to-brain delivery: Exploring newer domains for glioblastoma multiforme management, refAbstract=null), Reference(id=1208073019436671642, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=17, issue=4, pageStart=1193, pageEnd=1204, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=Ullah I, Chung K, Bae S, journalName=Mol Pharm, refType=null, unstructuredReference=Ullah I, Chung K, Bae S, et al. Nose-to-brain delivery of cancer-targeting paclitaxel-loaded nanoparticles potentiates antitumor effects in malignant glioblastoma[J]. Mol Pharm, 2020, 17(4):1193-1204., articleTitle=Nose-to-brain delivery of cancer-targeting paclitaxel-loaded nanoparticles potentiates antitumor effects in malignant glioblastoma, refAbstract=null), Reference(id=1208073019507974810, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=36, issue=9, pageStart=131, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=de Oliveira Junior ER, Nascimento TL, Salomão MA, journalName=Pharm Res, refType=null, unstructuredReference=de Oliveira Junior ER, Nascimento TL, Salomão MA, et al. Increased nose-to-brain delivery of melatonin mediated by polycaprolactone nanoparticles for the treatment of glioblastoma[J]. Pharm Res, 2019, 36(9):131., articleTitle=Increased nose-to-brain delivery of melatonin mediated by polycaprolactone nanoparticles for the treatment of glioblastoma, refAbstract=null), Reference(id=1208073019579277980, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=597, issue=null, pageStart=120250, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=Qu Y, Li A, Ma L, journalName=Int J Pharm, refType=null, unstructuredReference=Qu Y, Li A, Ma L, et al. Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy[J]. Int J Pharm, 2021, 597: 120250., articleTitle=Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy, refAbstract=null), Reference(id=1208073019667358366, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2013, volume=5, issue=3, pageStart=1020, pageEnd=1048, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=van Woensel M, Wauthoz N, Rosière R, journalName=Cancers (Basel), refType=null, unstructuredReference=van Woensel M, Wauthoz N, Rosière R, et al. Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?[J]. Cancers (Basel), 2013, 5(3): 1020-1048., articleTitle=Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?, refAbstract=null), Reference(id=1208073019763827360, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2017, volume=6, issue=10, pageStart=92, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=Hewlings SJ, Kalman DS, journalName=Foods, refType=null, unstructuredReference=Hewlings SJ, Kalman DS. Curcumin: A review of its effects on human health[J]. Foods, 2017, 6(10): 92., articleTitle=Curcumin: A review of its effects on human health, refAbstract=null), Reference(id=1208073020959204003, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=689, issue=null, pageStart=108412, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=Wang Z, Liu F, Liao W, journalName=Arch Biochem Biophys, refType=null, unstructuredReference=Wang Z, Liu F, Liao W, et al. Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression[J]. Arch Biochem Biophys, 2020, 689:108412., articleTitle=Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression, refAbstract=null), Reference(id=1208073021034701478, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2017, volume=17, issue=1, pageStart=99, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=Gersey ZC, Rodriguez GA, Barbarite E, journalName=BMC Cancer, refType=null, unstructuredReference=Gersey ZC, Rodriguez GA, Barbarite E, et al. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species[J]. BMC Cancer, 2017, 17(1): 99., articleTitle=Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species, refAbstract=null), Reference(id=1208073021118587558, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=57, issue=8, pageStart=3391, pageEnd=3411, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=Sahab-Negah S, Ariakia F, Jalili-Nik M, journalName=Mol Neurobiol, refType=null, unstructuredReference=Sahab-Negah S, Ariakia F, Jalili-Nik M, et al. Curcumin loaded in niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: An in vitro study[J]. Mol Neurobiol, 2020, 57(8): 3391-3411., articleTitle=Curcumin loaded in niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: An in vitro study, refAbstract=null), Reference(id=1208073021206667944, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2017, volume=51, issue=2, pageStart=467, pageEnd=477, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=Wang X, Deng J, Yuan J, journalName=Int J Oncol, refType=null, unstructuredReference=Wang X, Deng J, Yuan J, et al. Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells[J]. Int J Oncol, 2017, 51(2): 467-477., articleTitle=Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells, refAbstract=null), Reference(id=1208073021315719850, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2016, volume=139, issue=12, pageStart=2838, pageEnd=2849, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=Mukherjee S, Baidoo J, Fried A, journalName=Int J Cancer, refType=null, unstructuredReference=Mukherjee S, Baidoo J, Fried A, et al. Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma[J]. Int J Cancer, 2016, 139(12): 2838-2849., articleTitle=Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma, refAbstract=null), Reference(id=1208073021437354668, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=11, issue=1, pageStart=77, pageEnd=87, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=Machon C, Catez F, Venezia ND, journalName=J Pharm Anal, refType=null, unstructuredReference=Machon C, Catez F, Venezia ND, et al. Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method[J]. J Pharm Anal, 2021, 11(1):77-87., articleTitle=Study of intracellular anabolism of 5-fluorouracil and incorporation in nucleic acids based on an LC-HRMS method, refAbstract=null), Reference(id=1208073021533823662, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=111, issue=3, pageStart=283, pageEnd=291, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=Carvalho LA, Teng J, Fleming RL, journalName=J Natl Cancer Inst, refType=null, unstructuredReference=Carvalho LA, Teng J, Fleming RL, et al. Olfactory ensheathing cells: A trojan horse for glioma gene therapy[J]. J Natl Cancer Inst, 2019, 111(3): 283-291., articleTitle=Olfactory ensheathing cells: A trojan horse for glioma gene therapy, refAbstract=null), Reference(id=1208073021634486961, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2012, volume=5, issue=1, pageStart=102, pageEnd=114, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=Zhang J, Stevens MF, Bradshaw TD, journalName=Curr Mol Pharmacol, refType=null, unstructuredReference=Zhang J, Stevens MF, Bradshaw TD. Temozolomide: mechanisms of action, repair and resistance[J]. Curr Mol Pharmacol, 2012, 5(1): 102-114., articleTitle=Temozolomide: mechanisms of action, repair and resistance, refAbstract=null), Reference(id=1208073021714178740, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2014, volume=34, issue=5, pageStart=631, pageEnd=635, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=Li Y, Gao Y, Liu G, journalName=Nan Fang Yi Ke Da Xue Xue Bao, refType=null, unstructuredReference=Li Y, Gao Y, Liu G, et al. Intranasal administration of temozolomide for brain-targeting delivery: Therapeutic effect on glioma in rats[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2014, 34(5):631-635., articleTitle=Intranasal administration of temozolomide for brain-targeting delivery: Therapeutic effect on glioma in rats, refAbstract=null), Reference(id=1208073022100054710, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2015, volume=5, issue=5, pageStart=1580, pageEnd=1593, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=Chen TC, Fonseca CO, Schönthal AH, journalName=Am J Cancer Res, refType=null, unstructuredReference=Chen TC, Fonseca CO, Schönthal AH. Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy[J]. Am J Cancer Res, 2015, 5(5): 1580-1593., articleTitle=Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy, refAbstract=null), Reference(id=1208073022175552184, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=19, issue=12, pageStart=3905, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=Chen TC, da Fonseca CO, Schönthal AH, journalName=Int J Mol Sci, refType=null, unstructuredReference=Chen TC, da Fonseca CO, Schönthal AH. Intranasal perillyl alcohol for glioma therapy: Molecular mechanisms and clinical development[J]. Int J Mol Sci, 2018, 19(12): 3905., articleTitle=Intranasal perillyl alcohol for glioma therapy: Molecular mechanisms and clinical development, refAbstract=null), Reference(id=1208073022276215481, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=3, issue=1, pageStart=vdab005, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=Schönthal AH, Peereboom DM, Wagle N, journalName=Neurooncol Adv, refType=null, unstructuredReference=Schönthal AH, Peereboom DM, Wagle N, et al. Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma[J]. Neurooncol Adv, 2021, 3(1): vdab005., articleTitle=Phase I trial of intranasal NEO100, highly purified perillyl alcohol, in adult patients with recurrent glioblastoma, refAbstract=null), Reference(id=1208073022368490173, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2014, volume=44, issue=6, pageStart=1843, pageEnd=1852, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=Rieger J, Bahr O, Maurer GD, journalName=Int J Oncol, refType=null, unstructuredReference=Rieger J, Bahr O, Maurer GD, et al. ERGO: A pilot study of ketogenic diet in recurrent glioblastoma[J]. Int J Oncol, 2014, 44(6): 1843-1852., articleTitle=ERGO: A pilot study of ketogenic diet in recurrent glioblastoma, refAbstract=null), Reference(id=1208073022464959167, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=8, issue=1, pageStart=24, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=Klein P, Tyrlikova I, Zuccoli G, journalName=Cancer Metab, refType=null, unstructuredReference=Klein P, Tyrlikova I, Zuccoli G, et al. Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement[J]. Cancer Metab, 2020, 8(1): 24., articleTitle=Treatment of glioblastoma multiforme with "classic" 4:1 ketogenic diet total meal replacement, refAbstract=null), Reference(id=1208073022548845249, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=2, issue=null, pageStart=200, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=Mukherjee P, Augur ZM, Li M, journalName=Commun Biol, refType=null, unstructuredReference=Mukherjee P, Augur ZM, Li M, et al. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma[J]. Commun Biol, 2019, 2: 200., articleTitle=Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma, refAbstract=null), Reference(id=1208073022628537027, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2018, volume=15, issue=1, pageStart=1263, pageEnd=1270, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=Santos JG, Da Cruz WMS, Schönthal AH, journalName=Oncol Lett, refType=null, unstructuredReference=Santos JG, Da Cruz WMS, Schönthal AH, et al. Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma[J]. Oncol Lett, 2018, 15(1): 1263-1270., articleTitle=Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma, refAbstract=null), Reference(id=1208073022716617413, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2015, volume=3, issue=null, pageStart=3, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=Schwartz K, Chang HT, Nikolai M, journalName=Cancer Metab, refType=null, unstructuredReference=Schwartz K, Chang HT, Nikolai M, et al. Treatment of glioma patients with ketogenic diets: Report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature[J]. Cancer Metab, 2015, 3: 3., articleTitle=Treatment of glioma patients with ketogenic diets: Report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature, refAbstract=null), Reference(id=1208073022775337671, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=24, issue=23, pageStart=4312, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=Bruinsmann FA, Richter Vaz G, de Cristo Soares Alves A, journalName=Molecules, refType=null, unstructuredReference=Bruinsmann FA, Richter Vaz G, de Cristo Soares Alves A, et al. Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: Preclinical and clinical trials[J]. Molecules, 2019, 24(23): 4312., articleTitle=Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: Preclinical and clinical trials, refAbstract=null), Reference(id=1208073022846640841, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=9, issue=3, pageStart=599, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=Moretti E, Favero G, Rodella LF, journalName=Cells, refType=null, unstructuredReference=Moretti E, Favero G, Rodella LF, et al. Melatonin's antineoplastic potential against glioblastoma[J]. Cells, 2020, 9(3): 599., articleTitle=Melatonin's antineoplastic potential against glioblastoma, refAbstract=null), Reference(id=1208073022976664267, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=34, issue=2, pageStart=192, pageEnd=199, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=Neamati F, Asemi Z, journalName=Fundam Clin Pharmacol, refType=null, unstructuredReference=Neamati F, Asemi Z. The effects of melatonin on signaling pathways and molecules involved in glioma[J]. Fundam Clin Pharmacol, 2020, 34(2): 192-199., articleTitle=The effects of melatonin on signaling pathways and molecules involved in glioma, refAbstract=null), Reference(id=1208073023043773133, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=18, issue=3, pageStart=915, pageEnd=927, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=Wang L, Tang S, Yu Y, journalName=Mol Pharm, refType=null, unstructuredReference=Wang L, Tang S, Yu Y, et al. Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting[J]. Mol Pharm, 2021, 18(3): 915-927., articleTitle=Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting, refAbstract=null), Reference(id=1208073023119270607, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=8, issue=3, pageStart=2001960, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=Hua D, Tang L, Wang W, journalName=Adv Sci (Weinh), refType=null, unstructuredReference=Hua D, Tang L, Wang W, et al. Improved antiglioblastoma activity and BBB permeability by conjugation of paclitaxel to a cell-penetrative MMP-2-cleavable peptide[J]. Adv Sci (Weinh), 2020, 8(3): 2001960., articleTitle=Improved antiglioblastoma activity and BBB permeability by conjugation of paclitaxel to a cell-penetrative MMP-2-cleavable peptide, refAbstract=null), Reference(id=1208073023177990865, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2017, volume=8, issue=1, pageStart=53, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=Pacioni S, D'Alessandris QG, Giannetti S, journalName=Stem Cell Res Ther, refType=null, unstructuredReference=Pacioni S, D'Alessandris QG, Giannetti S, et al. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts[J]. Stem Cell Res Ther, 2017, 8(1): 53., articleTitle=Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts, refAbstract=null), Reference(id=1208073023253488339, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2017, volume=null, issue=124, pageStart=55845, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=Yu D, Li G, Lesniak MS, journalName=J Vis Exp, refType=null, unstructuredReference=Yu D, Li G, Lesniak MS, et al. Intranasal delivery of therapeutic stem cells to glioblastoma in a mouse model[J]. J Vis Exp, 2017, (124): 55845., articleTitle=Intranasal delivery of therapeutic stem cells to glioblastoma in a mouse model, refAbstract=null), Reference(id=1208073023328985813, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2020, volume=2020, issue=null, pageStart=8889061, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=Chia YC, Anjum CE, Yee HR, journalName=Stem Cells Int, refType=null, unstructuredReference=Chia YC, Anjum CE, Yee HR, et al. Stem cell therapy for neurodegenerative diseases: How do stem cells bypass the blood-brain barrier and home to the brain?[J]. Stem Cells Int, 2020, 2020: 8889061., articleTitle=Stem cell therapy for neurodegenerative diseases: How do stem cells bypass the blood-brain barrier and home to the brain?, refAbstract=null), Reference(id=1208073023383511767, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=2021, issue=null, pageStart=5549381, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=Gutova M, Cheng JP, Adhikarla V, journalName=Stem Cells Int, refType=null, unstructuredReference=Gutova M, Cheng JP, Adhikarla V, et al. Intranasally administered L-Myc-immortalized human neural stem cells migrate to primary and distal sites of damage after cortical impact and enhance spatial learning[J]. Stem Cells Int, 2021, 2021: 5549381., articleTitle=Intranasally administered L-Myc-immortalized human neural stem cells migrate to primary and distal sites of damage after cortical impact and enhance spatial learning, refAbstract=null), Reference(id=1208073023471592153, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=12, issue=1, pageStart=210, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=Zhang YT, He KJ, Zhang JB, journalName=Stem Cell Res Ther, refType=null, unstructuredReference=Zhang YT, He KJ, Zhang JB, et al. Advances in intranasal application of stem cells in the treatment of central nervous system diseases[J]. Stem Cell Res Ther, 2021, 12(1): 210., articleTitle=Advances in intranasal application of stem cells in the treatment of central nervous system diseases, refAbstract=null), Reference(id=1208073023584838363, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2017, volume=23, issue=12, pageStart=2951, pageEnd=2960, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=Portnow J, Synold TW, Badie B, journalName=Clin Cancer Res, refType=null, unstructuredReference=Portnow J, Synold TW, Badie B, et al. Neural stem cell-based anticancer gene therapy: A first-in-human study in recurrent high-grade glioma patients[J]. Clin Cancer Res, 2017, 23(12):2951-2960., articleTitle=Neural stem cell-based anticancer gene therapy: A first-in-human study in recurrent high-grade glioma patients, refAbstract=null), Reference(id=1208073023689695965, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=21, issue=3, pageStart=213, pageEnd=222, url=null, language=null, rfNumber=[55], rfOrder=54, authorNames=Coccè V, Bonomi A, Cavicchini L, journalName=Curr Cancer Drug Targets, refType=null, unstructuredReference=Coccè V, Bonomi A, Cavicchini L, et al. Paclitaxel priming of TRAIL expressing mesenchymal stromal cells (MSCs-TRAIL)increases antitumor efficacy of their secretome[J]. Curr Cancer Drug Targets, 2021, 21(3): 213-222., articleTitle=Paclitaxel priming of TRAIL expressing mesenchymal stromal cells (MSCs-TRAIL)increases antitumor efficacy of their secretome, refAbstract=null), Reference(id=1208073023756804831, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=10, issue=1, pageStart=88, pageEnd=null, url=null, language=null, rfNumber=[56], rfOrder=55, authorNames=Li M, Sun S, Dangelmajer S, journalName=Stem Cell Res Ther, refType=null, unstructuredReference=Li M, Sun S, Dangelmajer S, et al. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma[J]. Stem Cell Res Ther, 2019, 10(1): 88., articleTitle=Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma, refAbstract=null), Reference(id=1208073023857468129, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=13, issue=null, pageStart=204, pageEnd=null, url=null, language=null, rfNumber=[57], rfOrder=56, authorNames=Soria B, Martin-Montalvo A, Aguilera Y, journalName=Front Cell Neurosci, refType=null, unstructuredReference=Soria B, Martin-Montalvo A, Aguilera Y, et al. Human mesenchymal stem cells prevent neurological complications of radiotherapy[J]. Front Cell Neurosci, 2019, 13: 204., articleTitle=Human mesenchymal stem cells prevent neurological complications of radiotherapy, refAbstract=null), Reference(id=1208073023941354210, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2021, volume=13, issue=5, pageStart=1169, pageEnd=null, url=null, language=null, rfNumber=[58], rfOrder=57, authorNames=Aguilera Y, Mellado-Damas N, Olmedo-Moreno L, journalName=Cancers (Basel), refType=null, unstructuredReference=Aguilera Y, Mellado-Damas N, Olmedo-Moreno L, et al. Preclinical safety evaluation of intranasally delivered human mesenchymal stem cells in juvenile mice[J]. Cancers (Basel), 2021, 13(5): 1169., articleTitle=Preclinical safety evaluation of intranasally delivered human mesenchymal stem cells in juvenile mice, refAbstract=null), Reference(id=1208073024016851683, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2014, volume=22, issue=1, pageStart=140, pageEnd=148, url=null, language=null, rfNumber=[59], rfOrder=58, authorNames=Balyasnikova IV, Prasol MS, Ferguson SD, journalName=Mol Ther, refType=null, unstructuredReference=Balyasnikova IV, Prasol MS, Ferguson SD, et al. Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors[J]. Mol Ther, 2014, 22(1): 140-148., articleTitle=Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors, refAbstract=null), Reference(id=1208073024071377636, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2012, volume=1, issue=12, pageStart=866, pageEnd=873, url=null, language=null, rfNumber=[60], rfOrder=59, authorNames=Reitz M, Demestre M, Sedlacik J, journalName=Stem Cells Transl Med, refType=null, unstructuredReference=Reitz M, Demestre M, Sedlacik J, et al. Intranasal delivery of neural stem/progenitor cells: A noninvasive passage to target intracerebral glioma[J]. Stem Cells Transl Med, 2012, 1(12):866-873., articleTitle=Intranasal delivery of neural stem/progenitor cells: A noninvasive passage to target intracerebral glioma, refAbstract=null), Reference(id=1208073024138486501, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, doi=null, pmid=null, pmcid=null, year=2019, volume=9, issue=7, pageStart=2071, pageEnd=2083, url=null, language=null, rfNumber=[61], rfOrder=60, authorNames=Spencer D, Yu D, Morshed RA, journalName=Theranostics, refType=null, unstructuredReference=Spencer D, Yu D, Morshed RA, et al. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma[J]. Theranostics, 2019, 9(7): 2071-2083., articleTitle=Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma, refAbstract=null)], funds=[Fund(id=1208073015368196639, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=31701007, language=EN, fundingSource=National Natural Science Foundation of China(31701007), fundOrder=null, country=null), Fund(id=1208073016462909984, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=31701007, language=CN, fundingSource=国家自然科学基金(31701007), fundOrder=null, country=null), Fund(id=1208073016588739109, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=82060503, language=EN, fundingSource=National Natural Science Foundation of China(82060503), fundOrder=null, country=null), Fund(id=1208073016693596716, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=82060503, language=CN, fundingSource=国家自然科学基金(82060503), fundOrder=null, country=null), Fund(id=1208073016806842930, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=ZYK024, language=EN, fundingSource=Postgraduate Research fund Project of Zunyi Medical University(ZYK024), fundOrder=null, country=null), Fund(id=1208073016886534708, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=ZYK024, language=CN, fundingSource=遵义医科大学研究生科研基金项目(ZYK024), fundOrder=null, country=null), Fund(id=1208073016970420794, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=, language=EN, fundingSource=Science and Technology Program of Guizhou Province(QKHJZ-2019-1334)(), fundOrder=null, country=null), Fund(id=1208073017054306880, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=, language=CN, fundingSource=贵州省科技计划项目(黔科合基础[2019]1334号)(), fundOrder=null, country=null), Fund(id=1208073017167553092, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=gzwjkj2019-1-033, language=EN, fundingSource=Science and Technology Fund Project of Guizhou Health Commission(gzwjkj2019-1-033), fundOrder=null, country=null), Fund(id=1208073017238856264, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=gzwjkj2019-1-033, language=CN, fundingSource=贵州省卫健委科学技术基金(gzwjkj2019-1-033), fundOrder=null, country=null), Fund(id=1208073017314353742, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=QJHKYZ-2017-198, language=EN, fundingSource=Development Project of Science and Technology Talents Supported by Education Department of Guizhou Province(QJHKYZ-2017-198), fundOrder=null, country=null), Fund(id=1208073017406628432, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, awardId=QJHKYZ-2017-198, language=CN, fundingSource=贵州省教育厅青年科技人才成长项目(QJHKYZ-2017-198), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1208073012125999458, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=1, ext=[AuthorCompanyExt(id=1208073012130193763, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012125999458, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹Department of Pathophysiology, School of Preclinical Medicine, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012138582372, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012125999458, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=¹遵义医科大学基础医学院病理生理学教研室，贵州遵义 563000)]), AuthorCompany(id=1208073012281188715, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=2, ext=[AuthorCompanyExt(id=1208073012289577324, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012281188715, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=²First Clinical College, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012302160237, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012281188715, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=²遵义医科大学第一临床学院，贵州遵义 563000)]), AuthorCompany(id=1208073012432183669, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, xref=3, ext=[AuthorCompanyExt(id=1208073012474126712, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012432183669, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=³School of Stomatology, Zunyi Medical University, Zunyi, Guizhou 563000, China), AuthorCompanyExt(id=1208073012486709623, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, companyId=1208073012432183669, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=³遵义医科大学口腔医学院，贵州遵义 563000)])], figs=[ArticleFig(id=1208073014919406098, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=EN, label=Fig. 1, caption=The nose-to-brain drug delivery approaches for treatment of glioblastoma (GBM), figureFileSmall=kTiDPThOWuXoUR4QjZb1zg==, figureFileBig=g6GGK7ECmd4pG9fo2V8JMw==, tableContent=null), ArticleFig(id=1208073015003292181, tenantId=1146029695717560320, journalId=1189873630562394117, articleId=1208073009877852439, language=CN, label=图1, caption=鼻脑给药途径治疗胶质母细胞瘤(GBM), figureFileSmall=kTiDPThOWuXoUR4QjZb1zg==, figureFileBig=g6GGK7ECmd4pG9fo2V8JMw==, tableContent=null)], attaches=null, journal=Journal(id=1146441329971666965, delFlag=0, nameCn=解放军医学杂志, nameEn=Medical Journal of Chinese People’s Liberation Army, nameHistory1=null, nameHistory2=null, issn=0577-7402, eissn=null, cn=11-1056/R, coden=null, periodic=0, language=CN, oaType=是, ccby=CC BY-NC-ND, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=6srot5PcoYX30Oa4xeTmeg==, journalPrice=null, startedYear=null, abbrevIsoEn=null, journalRemark=null, publicationField=null, createdTime=1751262512917, updatedTime=1761735725513, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=M, firstLetterEn=M, subjectCode=Life Sciences, subjectName=Life Sciences, subjectCodeEn=Life Sciences, subjectNameEn=null, picCn=6srot5PcoYX30Oa4xeTmeg==, picEn=ELwBh5xqrSTlIs7HmSNt2Q==, jcr=null, cjcr=null, exts=[JournalExt(id=1190369167564968109, language=CN, name=解放军医学杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1761735725537, updatedTime=1761735725537, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=#, submissionEditorUrl=#, submissionReviewUrl=#, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1190369167615299758, language=EN, name=Medical Journal of Chinese People’s Liberation Army, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1761735725549, updatedTime=1761735725549, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=#, submissionEditorUrl=#, submissionReviewUrl=#, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1189873630562394117, websiteList=[Website(id=1189873845923287108, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1189873630562394117, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/jfjyxzz/CN, language=CN, createTime=1761617631655, createBy=18614031015, updateTime=1761622010471, updateBy=18614031015, name=解放军医学杂志-中文, tplId=1146099689490845704, title=解放军医学杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1189924939378520839, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=articleTextType, value=kx, createTime=1761629813284, updateTime=1761629813284, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939353355012, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=banner, value=null, createTime=1761629813278, updateTime=1761629813278, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939399492362, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=grayFlag, value=0, createTime=1761629813289, updateTime=1761629813289, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939344966403, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=logo, value=https://castjournals.cast.org.cn/joweb/jfjyxzz/CN/file/pic?fileId=+zXjYVhun8ZOAA6+aKx2hw==, createTime=1761629813276, updateTime=1761629813276, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939412075276, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=minRunFlag, value=0, createTime=1761629813292, updateTime=1761629813292, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939374326534, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/jfjyxzz/CN/file/pic, createTime=1761629813283, updateTime=1761629813283, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939407880971, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=silenceFlag, value=0, createTime=1761629813291, updateTime=1761629813291, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939361743621, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1761629813280, updateTime=1761629813280, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939386909448, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=themeColor, value=null, createTime=1761629813286, updateTime=1761629813286, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924939395298057, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873845923287108, code=themeStyle, value=null, createTime=1761629813288, updateTime=1761629813288, creator=18614031015, updator=18614031015)]), Website(id=1189873846057504839, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1189873630562394117, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/jfjyxzz/EN, language=EN, createTime=1761617631687, createBy=18614031015, updateTime=1761622030030, updateBy=18614031015, name=解放军医学杂志-英文, tplId=1146101810881728533, title=Medical Journal of Chinese People’s Liberation Army, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1189924968168223505, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=articleTextType, value=kx, createTime=1761629820148, updateTime=1761629820148, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968147251982, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=banner, value=null, createTime=1761629820143, updateTime=1761629820143, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968185000724, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=grayFlag, value=0, createTime=1761629820152, updateTime=1761629820152, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968138863373, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=logo, value=https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/file/pic?fileId=+zXjYVhun8ZOAA6+aKx2hw==, createTime=1761629820141, updateTime=1761629820141, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968197583638, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=minRunFlag, value=0, createTime=1761629820155, updateTime=1761629820155, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968159834896, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/file/pic, createTime=1761629820146, updateTime=1761629820146, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968193389333, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=silenceFlag, value=0, createTime=1761629820154, updateTime=1761629820154, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968155640591, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1761629820145, updateTime=1761629820145, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968172417810, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=themeColor, value=null, createTime=1761629820149, updateTime=1761629820149, creator=18614031015, updator=18614031015), WebsiteProps(id=1189924968180806419, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1189873846057504839, code=themeStyle, value=null, createTime=1761629820151, updateTime=1761629820151, creator=18614031015, updator=18614031015)])], journalTitle=解放军医学杂志, weixinUrl=null, journalUrl=http://zh.jfjyxzz.org.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Medical Journal of Chinese People’s Liberation Army, journalPhotoCn=6srot5PcoYX30Oa4xeTmeg==, journalPhotoEn=ELwBh5xqrSTlIs7HmSNt2Q==, journalFirstLetter=M, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false), detailUrlCn=https://castjournals.cast.org.cn/joweb/jfjyxzz/CN/10.11855/j.issn.0577-7402.2022.05.0511, detailUrlEn=https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/10.11855/j.issn.0577-7402.2022.05.0511, pdfUrlCn=https://castjournals.cast.org.cn/joweb/jfjyxzz/CN/PDF/10.11855/j.issn.0577-7402.2022.05.0511, pdfUrlEn=https://castjournals.cast.org.cn/joweb/jfjyxzz/EN/PDF/10.11855/j.issn.0577-7402.2022.05.0511, aliStartDate=null, aliEndDate=null, collectionFlag=false, citedCount=null, citedUrl=null, reference=null)